Consolidating evidence on the role of insulin resistance in major depressive disorder

AJ Krupa, D Dudek, M Siwek - Current Opinion in Psychiatry, 2024 - journals.lww.com
Consolidating evidence on the role of insulin resistance in... : Current Opinion in Psychiatry
Consolidating evidence on the role of insulin resistance in major depressive disorder : Current …

Paolo Brambilla, PhD, MD Possible role of metformin as an antidepressant in diabetes. Review

A Pedreañez, Y Carrero, R Vargas… - Journal of affective …, 2024 - Elsevier
Objective Metformin (MET) is a drug used in the treatment of type 2 diabetes due to its
insulin receptor sensitizing properties and anti-hepatic gluconeogenesis effect. One of the …

Resilience and Vulnerability to Stress-Induced Anhedonia: Unveiling Brain Gene Expression and Mitochondrial Dynamics in a Mouse Chronic Stress Depression …

T Strekalova, E Svirin, A Gorlova, E Sheveleva… - Biomolecules, 2023 - mdpi.com
The role of altered brain mitochondrial regulation in psychiatric pathologies, including Major
Depressive Disorder (MDD), has attracted increasing attention. Aberrant mitochondrial …

Integrating metabolomics and network pharmacology to explore the mechanism of Xiao-Yao-San in the treatment of inflammatory response in CUMS mice

Y Zhang, XJ Li, XR Wang, X Wang, GH Li, QY Xue… - Pharmaceuticals, 2023 - mdpi.com
Depression can trigger an inflammatory response that affects the immune system, leading to
the development of other diseases related to inflammation. Xiao-Yao-San (XYS) is a …

Effects of weight loss intervention on anxiety, depression and quality of life in women with severe obesity and polycystic ovary syndrome

J Kataoka, M Olsson, E Lindgren, I Larsson… - Scientific Reports, 2024 - nature.com
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women that is
associated with an increased risk of anxiety and depression and with a lower health-related …

Higher serum chromium level may be associated with the presentation of depression in patients with metabolic dysfunction-associated fatty liver disease: evidence …

X Li, X Xia, B Jiang, Y Yao, F Ding, S Qin - Frontiers in Psychiatry, 2024 - frontiersin.org
Background Depressive symptoms are frequently observed in patients with Metabolic
Dysfunction-Associated Fatty Liver Disease (MAFLD), a prevalent metabolic disorder that …

Symptoms of anxiety and depression and health-related quality of life in women with severe obesity and polycystic ovary syndrome and the effect of a one year weight …

J Kataoka, M Olsson, E Lindgren, I Larsson, J Schmidt… - 2023 - researchsquare.com
Background Polycystic ovary syndrome (PCOS) is a common endocrine disorder among
women, with more reported symptoms of anxiety, depression and lower health related …

Psikotik bozukluğu ve duygudurum bozukluğu olan çocuk ve ergenlerde peroksizom proliferatif aktivatör (PPAR) gama reseptörünün serum düzeyinin duygudurum …

A Karaca - 2023 - acikerisim.uludag.edu.tr
Çalışmamızın amacı major depresif bozukluk (MDB) ve psikotik özellikli major depresif
bozukluk (PÖD) tanılı çocuk ve ergenlerdeki peroksizom proliferatif aktivatör reseptör gama …

Psi̇koti̇k Bozukluğu ve Duygudurum Bozukluğu Olan Çocuk ve Ergenlerde Peroksi̇zom Proli̇ferati̇f Akti̇vatör (PPAR) Gama Reseptörünün Serum …

A Karaca - 2023 - search.proquest.com
Çalışmamızın amacı major depresif bozukluk (MDB) ve psikotik özellikli major depresif
bozukluk (PÖD) tanılı çocuk ve ergenlerdeki peroksizom proliferatif aktivatör reseptör gama …